SCHEMBL31661790

SCHEMBL31661790

Cn1cc(C(F)(F)F)nc1-c1ccc(-c2nc(-c3cc(Br)ccc3F)no2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 4/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 1/20 0.39
THRB P10828 1/20 0.39
S1PR1 P21453 7/20 0.38
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
MAPT P10636 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
PKM P14618 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31661802 0.93 NPC1 (0.43) NPC1HTTRAB9ALMNATHRB
SCHEMBL31661744 0.85 NR1H4 (0.50) NPC1RAB9ALMNATHRBS1PR1
SCHEMBL31661762 0.85 NR1H4 (0.50) NPC1RAB9ALMNATHRBS1PR1
SCHEMBL31661724 0.83 USP1 (0.41) NPC1RAB9ATSHRS1PR1SMN1; SMN2
SCHEMBL31661659 0.83 LMNA (0.55) NPC1HTTRAB9ATSHRLMNA
SCHEMBL31661726 0.79 USP1 (0.41) HTTS1PR1ALDH1A1SMN1; SMN2USP1
SCHEMBL31661695 0.79 S1PR1 (0.46) S1PR1SMN1; SMN2NFKB1NFKB2RELA
SCHEMBL31661671 0.78 S1PR1 (0.47) S1PR1SMN1; SMN2NPSR1USP1
SCHEMBL31661764 0.78 RAB9A (0.43) NPC1RAB9ALMNATHRBS1PR1
SCHEMBL22165856 0.77 PTGS2 (0.44) HTTTP53USP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151705-A1 NOVEL INHIBITORS OF DNA DAMAGE REPAIR PATHWAY VRISE THERAPEUTICS, INC. (US) 2025-07-17 WO disclosed